GeoVax to Participate in Upcoming Investor Conferences in September

ATLANTA, GA, Sept. 03, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced that its Chairman and CEO, David Dodd, will present at two upcoming investor events: | --- | |---------------| | | | Speaker: | | Date/Time: | | Location: | | Webcast Link: | | Title: | H.C. Wainwright 26th Annual Global Investment Conference | --- | |-------------------------------------------| | | | | | Da ...